Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic Modifications: Therapeutic Potential in Cancer

Epigenetic modifications and alterations in chromatin structure and function contribute to the cumulative changes observed as normal cells undergo malignant transformation. These modifications and enzymes (DNA methyltransferases, histone deacetylases, histone methyltransferases, and demethylases) re...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Manisha Sachan, Manpreet Kaur
Format:	Artikel
Sprache:	English
Veröffentlicht:	Instituto de Tecnologia do Paraná (Tecpar) 2015-08-01
Schriftenreihe:	Brazilian Archives of Biology and Technology
Schlagworte:	HDAC inhibitors Cancer epigenetics Histone modification
Online Zugang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132015000400526&lng=en&tlng=en

Ähnliche Einträge

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
von: Michelle Esposito, et al.
Veröffentlicht: (2019-05-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
von: Guo Li, et al.
Veröffentlicht: (2020-09-01)

Implication des modifications épigénétiques dans les cancers : développement de nouvelles approches thérapeutiques
von: Willems L., et al.
Veröffentlicht: (2008-01-01)

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
von: Xiaomin Wang, et al.
Veröffentlicht: (2023-06-01)

Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
von: Delcuve Geneviève P, et al.
Veröffentlicht: (2012-03-01)

The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
von: Dineo eKhabele
Veröffentlicht: (2014-05-01)

dCas9-HDAC8-EGFP fusion enables epigenetic editing of breast cancer cells by H3K9 deacetylation
von: Mohammad Mijanur Rahman, et al.
Veröffentlicht: (2024-12-01)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
von: Qingfan Yang, et al.
Veröffentlicht: (2022-01-01)

Epigenetic regulation by gut microbiota
von: Vivienne Woo, et al.
Veröffentlicht: (2022-12-01)

Epigenetic modification enzymes: catalytic mechanisms and inhibitors
von: Duo Lu
Veröffentlicht: (2013-05-01)

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
von: Dusan Ruzic, et al.
Veröffentlicht: (2022-01-01)

Epigenetic control of the vicious cycle
von: Madeline B. Searcy, et al.
Veröffentlicht: (2024-02-01)

The role of HDAC3 in inflammation: mechanisms and therapeutic implications
von: Noah Watson, et al.
Veröffentlicht: (2024-07-01)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
von: Yu Wang, et al.
Veröffentlicht: (2022-05-01)

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
von: Flavia Lima Costa Faldoni, et al.
Veröffentlicht: (2020-05-01)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
von: Xilan Yu, et al.
Veröffentlicht: (2018-09-01)

Histones and their modifications in ovarian cancer – drivers of disease and therapeutic targets
von: Deborah Joy Marsh, et al.
Veröffentlicht: (2014-06-01)

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS
von: V. P. Maksimova, et al.
Veröffentlicht: (2020-09-01)

From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
von: Jin-xu Fang, et al.
Veröffentlicht: (2011-12-01)

Mechanisms and technologies in cancer epigenetics
von: Zaki A. Sherif, et al.
Veröffentlicht: (2025-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
von: Kelly N. Hassell
Veröffentlicht: (2019-11-01)

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
von: Ibrahim S. Alalhareth, et al.
Veröffentlicht: (2025-02-01)

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
von: Louis Legoff, et al.
Veröffentlicht: (2021-08-01)

Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
von: Hana Q. Sadida, et al.
Veröffentlicht: (2024-01-01)

The proteasome and epigenetics: zooming in on histone modifications
von: Bach Svitlana V., et al.
Veröffentlicht: (2016-08-01)

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
von: Yi Luan, et al.
Veröffentlicht: (2022-04-01)

Epigenetics modifications and therapeutic prospects in human thyroid cancer
von: Maria Graziella eCatalano, et al.
Veröffentlicht: (2012-03-01)

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus
von: Xiaojie Wang, et al.
Veröffentlicht: (2012-08-01)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
von: Vera Miranda-Gonçalves, et al.
Veröffentlicht: (2018-10-01)

Connections between metabolism and epigenetic modifications in cancer
von: Wang Guangchao, et al.
Veröffentlicht: (2021-12-01)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
von: Wenjing Xiao, et al.
Veröffentlicht: (2021-09-01)

Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
von: Srinivas Patnaik, et al.
Veröffentlicht: (2019-06-01)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
von: Maria R. Pozo, et al.
Veröffentlicht: (2022-01-01)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
von: Vera Miranda-Gonçalves, et al.
Veröffentlicht: (2019-09-01)

Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia
von: Abhinav Dhall, et al.
Veröffentlicht: (2019-05-01)

Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities
von: Reyhaneh Farrokhi Yekta, et al.
Veröffentlicht: (2024-10-01)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
von: Reem Saleh, et al.
Veröffentlicht: (2020-07-01)

Epigenetic Modifications of Host Genes Induced by Bacterial Infection
von: Maryam Parhamfar, et al.
Veröffentlicht: (2021-08-01)

NSD family proteins: Rising stars as therapeutic targets
von: Lin He, et al.
Veröffentlicht: (2024-04-01)

Pulmonary Pathogen-Induced Epigenetic Modifications
von: Dylan Wrede, et al.
Veröffentlicht: (2023-07-01)